Investments | Investments Debt Securities As of April 30, 2023, debt securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 2,438,041 $ 975 $ (5,348) $ 2,433,668 U.S. agency obligations 479,204 720 (2,307) 477,617 Corporate bonds 1,484,215 3,604 (7,243) 1,480,576 Commercial paper 1,160,709 — — 1,160,709 Total debt securities $ 5,562,169 $ 5,299 $ (14,898) $ 5,552,570 Included in Cash and cash equivalents $ 732,881 $ 5 $ (2) $ 732,884 Included in Marketable securities $ 4,829,288 $ 5,294 $ (14,896) $ 4,819,686 As of January 31, 2023, debt securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value U.S. treasury securities $ 2,455,739 $ 77 $ (6,765) $ 2,449,051 U.S. agency obligations 325,664 — (3,874) 321,790 Corporate bonds 966,801 1,617 (6,715) 961,703 Commercial paper 1,016,641 — (5) 1,016,636 Total debt securities $ 4,764,845 $ 1,694 $ (17,359) $ 4,749,180 Included in Cash and cash equivalents $ 594,864 $ — $ (1) $ 594,863 Included in Marketable securities $ 4,169,980 $ 1,694 $ (17,357) $ 4,154,317 We classify our debt securities as available-for-sale at the time of purchase and reevaluate such classification as of each balance sheet date. We consider all debt securities as funds available for use in current operations, including those with maturity dates beyond one year, and therefore classify these securities as current assets on the Condensed Consolidated Balance Sheets. Debt securities included in Marketable securities on the Condensed Consolidated Balance Sheets consist of securities with original maturities at the time of purchase greater than three months, and the remaining securities are included in Cash and cash equivalents. As of April 30, 2023, and January 31, 2023, the fair value of debt securities in an unrealized loss position was $3.0 billion and $3.1 billion, respectively, the majority of which had been in a continuous unrealized loss position for less than 12 months. We did not recognize any credit or non-credit related losses related to our debt securities during the periods presented. We sold $12 million of debt securities during the three months ended April 30, 2023, and the realized gains and losses from the sales were immaterial. We did not have any sales of debt securities during the three months ended April 30, 2022. Equity Investments Equity investments consisted of the following (in thousands): Condensed Consolidated Balance Sheets Location April 30, 2023 January 31, 2023 Money market funds Cash and cash equivalents $ 486,603 $ 902,226 Non-marketable equity investments measured using the measurement alternative Other assets 269,622 261,922 Marketable equity investments Marketable securities 65,624 80,766 Total equity investments $ 821,849 $ 1,244,914 Total realized and unrealized gains and losses associated with our equity investments consisted of the following (in thousands): Three Months Ended April 30, 2023 2022 Net realized gains (losses) recognized on equity investments sold (1) $ 55 $ 1,059 Net unrealized gains (losses) recognized on equity investments held as of the end of the period (8,068) (8,488) Total net gains (losses) recognized in Other income (expense), net $ (8,013) $ (7,429) (1) Reflects the difference between the sale proceeds and the carrying value of the equity investments at the beginning of the period. Non-Marketable Equity Investments Measured Using the Measurement Alternative Non-marketable equity investments measured using the measurement alternative include investments in privately held companies without readily determinable fair values in which we do not own a controlling interest or exercise significant influence. These investments are recorded at cost and are adjusted for observable transactions for same or similar securities of the same issuer or impairment events. The carrying values for our non-marketable equity investments are summarized below (in thousands): April 30, 2023 January 31, 2023 Total initial cost $ 217,333 $ 206,833 Cumulative net unrealized gains (losses) 52,289 55,089 Carrying value $ 269,622 $ 261,922 During the three months ended April 30, 2023, and 2022, we recorded impairment losses of $3 million and $14 million, respectively. During the three months ended April 30, 2023, we recorded no upward adjustments to the carrying value of non-marketable equity investments and $3 million in the three months ended April 30, 2022. Marketable Equity Investments We hold marketable equity investments with readily determinable fair values over which we do not own a controlling interest or exercise significant influence. The carrying values for our marketable equity investments are summarized below (in thousands): April 30, 2023 January 31, 2023 Total initial cost $ 33,718 $ 38,449 Cumulative net unrealized gains (losses) 31,906 42,317 Carrying value $ 65,624 $ 80,766 During the three months ended April 30, 2023, we sold marketable equity investments for proceeds of $10 million with an immaterial corresponding realized gain. During the three months ended April 30, 2022, we sold marketable equity investments for proceeds of $5 million with corresponding realized gains of $1 million. During the three months ended April 30, 2023, and 2022, we recorded unrealized losses of $5 million and gains of $3 million, respectively, on marketable equity investments held as of the end of each period. |